These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 38140105)

  • 21. Predicting the correct dose in children: Role of computational Pediatric Physiological-based pharmacokinetics modeling tools.
    Zhou X; Dun J; Chen X; Xiang B; Dang Y; Cao D
    CPT Pharmacometrics Syst Pharmacol; 2023 Jan; 12(1):13-26. PubMed ID: 36330677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
    van Hoogdalem MW; Johnson TN; McPhail BT; Kamatkar S; Wexelblatt SL; Ward LP; Christians U; Akinbi HT; Vinks AA; Mizuno T
    Clin Pharmacol Ther; 2022 Feb; 111(2):496-508. PubMed ID: 34679189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
    Verscheijden LFM; Koenderink JB; Johnson TN; de Wildt SN; Russel FGM
    Pharmacol Ther; 2020 Jul; 211():107541. PubMed ID: 32246949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mahmood I; Ahmad T; Mansoor N; Sharib SM
    J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of PBPK modeling across the pediatric age range using propofol as a case.
    Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of Physiologically Based Pharmacokinetic Model of Levetiracetam to Predict Exposure and Dose Optimization in Pediatrics.
    Shao W; Shen C; Wang W; Sun H; Wang X; Geng K; Wang X; Xie H
    J Pharm Sci; 2023 Oct; 112(10):2667-2675. PubMed ID: 37023853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics.
    Adiwidjaja J; Boddy AV; McLachlan AJ
    Front Pharmacol; 2019; 10():1672. PubMed ID: 32082165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
    Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically Based Pharmacokinetic Model for Older Adults and Its Application in Geriatric Drug Research.
    Wu X; Sia JEV; Hai M; Lai X; Li H; Cui C; Liu D
    Curr Drug Metab; 2023; 24(3):211-222. PubMed ID: 37165496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of
    Loisios-Konstantinidis I; Dressman J
    Mol Pharm; 2021 Jan; 18(1):1-17. PubMed ID: 33320002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach.
    Li S; Xie F
    Br J Clin Pharmacol; 2023 Apr; 89(4):1402-1412. PubMed ID: 36357171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates.
    Smits A; Annaert P; Van Cruchten S; Allegaert K
    Front Pharmacol; 2020; 11():587. PubMed ID: 32477113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective.
    Lin W; Chen Y; Unadkat JD; Zhang X; Wu D; Heimbach T
    Pharm Res; 2022 Aug; 39(8):1701-1731. PubMed ID: 35552967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologically Based Pharmacokinetics Modeling in the Neonatal Population-Current Advances, Challenges, and Opportunities.
    Dinh J; Johnson TN; Grimstein M; Lewis T
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs.
    Munir A; Azam S; Fazal S; Bhatti AI
    J Theor Biol; 2018 Aug; 451():1-9. PubMed ID: 29704489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK.
    Zazo H; Lagarejos E; Prado-Velasco M; Sánchez-Herrero S; Serna J; Rueda-Ferreiro A; Martín-Suárez A; Calvo MV; Pérez-Blanco JS; Lanao JM
    Front Pharmacol; 2022; 13():977372. PubMed ID: 36249803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New Drugs.
    Wu F; Shah H; Li M; Duan P; Zhao P; Suarez S; Raines K; Zhao Y; Wang M; Lin HP; Duan J; Yu L; Seo P
    AAPS J; 2021 Feb; 23(2):31. PubMed ID: 33619657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.